Your browser doesn't support javascript.
loading
Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids.
Moir, Michael; Lane, Samuel; Lai, Felcia; Connor, Mark; Hibbs, David E; Kassiou, Michael.
Afiliación
  • Moir M; School of Chemistry, The University of Sydney, NSW, 2006, Australia.
  • Lane S; Faculty of Health Sciences, The University of Sydney, NSW, 2006, Australia.
  • Lai F; Sydney Pharmacy School, The University of Sydney, NSW, 2006, Australia.
  • Connor M; Department of Biomedical Sciences, Macquarie University, NSW, 2109, Australia.
  • Hibbs DE; Sydney Pharmacy School, The University of Sydney, NSW, 2006, Australia.
  • Kassiou M; School of Chemistry, The University of Sydney, NSW, 2006, Australia. Electronic address: michael.kassiou@sydney.edu.au.
Eur J Med Chem ; 180: 291-309, 2019 Oct 15.
Article en En | MEDLINE | ID: mdl-31319265

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabinoides / Receptor Cannabinoide CB2 / Indoles Límite: Animals Idioma: En Revista: Eur J Med Chem Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabinoides / Receptor Cannabinoide CB2 / Indoles Límite: Animals Idioma: En Revista: Eur J Med Chem Año: 2019 Tipo del documento: Article País de afiliación: Australia
...